Abiopharma

🔍 DeVries James E (Executive)

Company: NORDSON CORP (NDSN)

Report Date: 2025-12-29

Detailed Transactions and Holdings:

• Sold 1,247 shares of NDSN (Direct)
  Date: 2025-12-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 50,104.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 71 shares of NDSN at $275.28 per share (Direct)
  Date: 2026-04-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 50,033.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 127 shares of NDSN at $275.28 per share (Direct)
  Date: 2026-04-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 49,906.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of NDSN (Direct)
  Date: 2025-12-29 | Code: H | nature_of_ownership: Company Savings Plan | shares_owned_after: 809.00 | Footnotes: F4, F5
• Holds 6,600 shares of NDSN at $107.65 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2026-11-21 | Exercise: 2017-11-21 | shares_owned_after: 6,600.00 | Footnotes: F6, F7
• Holds 6,500 shares of NDSN at $127.67 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2027-11-20 | Exercise: 2018-11-20 | shares_owned_after: 6,500.00 | Footnotes: F6, F7
• Holds 6,100 shares of NDSN at $124.9 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2028-11-26 | Exercise: 2019-11-26 | shares_owned_after: 6,100.00 | Footnotes: F6, F7
• Holds 6,175 shares of NDSN at $165.21 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2029-11-25 | Exercise: 2020-11-25 | shares_owned_after: 6,175.00 | Footnotes: F6, F7
• Holds 5,200 shares of NDSN at $201.5 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2030-11-23 | Exercise: 2021-11-23 | shares_owned_after: 5,200.00 | Footnotes: F6, F7
• Holds 4,476 shares of NDSN at $267.51 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2031-11-22 | Exercise: 2022-11-22 | shares_owned_after: 4,476.00 | Footnotes: F6, F7
• Holds 4,093 shares of NDSN at $240.01 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2032-12-01 | Exercise: 2023-12-01 | shares_owned_after: 4,093.00 | Footnotes: F6, F7
• Holds 2,962 shares of NDSN at $238.8 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2033-12-01 | Exercise: 2024-12-01 | shares_owned_after: 2,962.00 | Footnotes: F6, F7
• Holds 2,836 shares of NDSN at $209.73 per share (Derivative)
  Date: 2025-12-29 | Code: H | Expires: 2034-12-20 | Exercise: 2025-12-20 | shares_owned_after: 2,836.00 | Footnotes: F6, F7

Footnotes:

• F1: The reporting person inadvertently failed to report this bona fide gift within the time period required under Section 16(a) of the Securities Exchange Act of 1934. The gift is being reported in this Form 4 as part of the reporting person's final Section 16 filing following retirement.
• F2: On December 1, 2023, the Company granted 716 restricted share units vesting in equal one-third installments over three years. Upon the reporting person's retirement, all unvested restricted share units accelerated and vested on April 16, 2026. 71 of the restricted share units were withheld to cover withholding taxes due upon vesting.
• F3: On December 20, 2024, the Company granted 641 restricted share units vesting in equal one-third installments over three years. Upon the reporting person's retirement, all unvested restricted share units accelerated and vested on April 16, 2026. 127 of the restricted share units were withheld to cover withholding taxes due upon vesting.
• F4: The change in holdings reflects an internal, non-cash reallocation within the reporting person's exempt company savings plan from a lower-priced fund to a higher-priced fund; no securities were sold.
• F5: Represents the number of shares attributable to the reporting person's participation in the Company Savings Plan, exempt pursuant to Rule 16b-3(c).
• F6: Expiration date of stock options did not change upon retirement of the reporting person from the Company.
• F7: Represents the number of derivative securities beneficially owned by reporting person following his retirement from the Company.